Ship Healthcare Holdings (3360) Fundamentals 2026 — P/E 16.4x, Revenue Analysis | SniperIQ
Ship Healthcare Holdings (3360) is a JP-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of ¥218.0B, trading at ¥2369.00 on the JPX. This SniperIQ fundamentals page covers Ship Healthcare Holdings's valuation (P/E 16.4x, P/B 1.4x), profitability (net margin 1.9%), revenue (¥718.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Ship Healthcare Holdings's market cap?
Ship Healthcare Holdings (3360) has a market capitalization of approximately ¥218.0B, trading at ¥2369.00 on the JPX. Market cap moves with the live share price.
What is Ship Healthcare Holdings's P/E ratio?
Ship Healthcare Holdings's trailing twelve-month P/E ratio is 16.4x, with a price-to-book (P/B) of 1.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Ship Healthcare Holdings?
Ship Healthcare Holdings runs a net profit margin of 1.9%, a gross margin of 9.3%, and an operating margin of 3.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Ship Healthcare Holdings generate?
Ship Healthcare Holdings reported revenue of ¥718.2B for fiscal year 2025, with net income of ¥13.4B and earnings per share (EPS) of 144.18. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Ship Healthcare Holdings pay a dividend?
Ship Healthcare Holdings offers a trailing dividend yield of about 2.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Ship Healthcare Holdings financially healthy?
Ship Healthcare Holdings carries a debt-to-equity ratio of 0.20x and a current ratio of 1.38x, with a market beta of -0.06. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Ship Healthcare Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Ship Healthcare Holdings (3360) the key facts are: market cap ¥218.0B, P/E 16.4x, revenue ¥718.2B, 52-week range 1938-2839. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Ship Healthcare Holdings's full fundamentals live
Get Ship Healthcare Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.